- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04606953
Working Memory Training in Older Adults With Mild Cognitive Impairment : Impacts on Cognition and Ecological Activities (APT-II)
Working Memory Training With Attention Process Training (APT-II) in Older Adults With Mild Cognitive Impairment : Impacts on Cognition and Ecological Activities
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Older adults with Mild Cognitive Impairment (MCI) have an increased risk of developing dementia, but do not meet the criteria for dementia. Some of these individuals nevertheless remain in a stable state or even return to the norm. Currently, pharmacological treatments have not been shown to be sufficiently effective in treating cognitive deficits. The major challenge is to identify other therapeutic approaches to reduce the risk of cognitive impairment progressing to dementia. Deficits in working memory, which are very common in these individuals, have a prognostic value for progression to dementia of the Alzheimer's type. Cognitive re-education makes it possible to compensate, at least in part, for cognitive disorders with the ultimate goal of reducing their repercussions in daily life. Executive control training can improve working memory and attention, but how this gain is transferred to activities of daily living (ADLs) remains poorly understood to date. The generalization of cognitive gains to ADLs is crucial, however, as this generalization may contribute to patients' functional autonomy.
This project aims to evaluate the effectiveness of attention and working memory training (APT-II) on cognitive function and ecological activities in MCI patients by means of a single-blind randomized controlled trial. Working memory is involved in information manipulation and attentional processes. This ability is called upon in higher cognitive functions such as language, reasoning, comprehension, but also in various complex ADL situations. Deficits in working memory thus contribute significantly to other cognitive or functional impairments in MCI patients. To date, some working memory training has been shown to have an immediate impact on working memory in this population. However, long-term maintenance and impact on daily life have not been demonstrated in this population. Researchers of this study propose to fill this gap by using the APT-II (or Attention Process Training) program, which focuses on the transfer of cognitive gains from the start of training. Indeed, the APT-II program was translated from English to French by the scientific coordinator (S. Blanchet). The English version has already been validated in various populations with mild cognitive dysfunction following brain injury, stroke or small vessel brain disease. The efficacy of APT-II has never been studied in older adults with IBD. For the first time a research team evaluate the short- and long-term efficacy of this program in MCI patients on cognition and ADLs using virtual reality. This new technology provides an ecological and objective measure for the evaluation of memory and other cognitive functions while simulating naturalistic and controlled situations. The objective is therefore to evaluate the effectiveness of an attention and working memory training program (APT-II) on cognitive function in patients with MCI. To achieve this objective, patients with MCI are randomly assigned to an APT-II program or to a control group. Cognitive training with the APT-II program will include progressively more difficult and adaptive exercises and will be varied to facilitate near and far cognitive transfer. Attention, working memory and episodic memory are measured at different time intervals (before, immediately after, 3 and 6 months after training). A unique feature of the cognitive training program is its emphasis on generalization by teaching participants how to maximize the transfer of the attention management strategies learned during the sessions to their various ADLs requiring attention and executive control. Homework exercises targeting these different cognitive functions in ADLs are also provided between sessions.
The protocol is offered to elderly people with mild cognitive impairment. In this single-blind randomized controlled trial, participants are randomly assigned either to a "cognitive training" experimental group (n=20) or a "standard care" control group (n=20). Recruitment is multi-centric, and takes place via memory consultations from several sites: Tenon Hospital (collaboration with Dr Eric Bouvard), AP-HP Sorbonne University, and Dr Mettling's private neurology practice (Paris XI). MCI patients are selected according to the criteria of Petersen (2004). A battery of standardized neuropsychological tests is first administered to ensure that participants meet our criteria. Patients must be at least 55 years of age and have an impairment of attention, exécutive, memory and/or working memory as evidenced by impaired performance on tests assessing attention or executive function (score 1.5 standard deviation below the norm on these tests). Participants meeting the selection criteria are invited to continue the study. The project has already been approved by the Committee for the Protection of Persons (CPP) EST-III of the ANSM (BCR ID: 2018-A02377-48, N°CPP: 18.11.05, N° 18.08.21.66617). Patients in the experimental group receive the APT-II training program individually with a psychologist for 8 weeks (2 sessions/week). The exercises target different attentional components and working memory in the auditory-visual modalities. This exercices are of increasing difficulty while being adapted to each patient's profile in order to maximize the effects on cognitive reserve. During the sessions, the emphasis is on generalizing the gains towards the most problematic daily activities in order to reduce the impact of the patients' cognitive problems in their daily lives. Patients in the control group receive standard routine care. In order to test the impact of the APT-II training program on cognitive function and daily activities, cognitive and functional follow-up measures are administered in a blind condition just before (T0), after (T1), and 3 (T2) and 6 months (T3) after the intervention. The last two measures will be used to study long-term maintenance of earnings. The cognitive follow-up measures will test the effects of near (attention, working memory) and far (episodic memory) cognitive transfers and generalization to daily activities with questionnaires. Functional follow-up measures include a virtual reality task assessing episodic memory in the presence of interferences in order to examine the effects of training on an ecological situation with high demands on attentional resources.
MCI patients who received the APT-II training program should perform better on attention and working memory tasks after training, with a distant transfer to episodic memory tasks compared to the control group who received standard care during the training time interval. Following cognitive training, MCI patients should also be less susceptible to environmental interferences as assessed with the virtual reality task, while reporting fewer cognitive complaints in everyday life with maintenance of these gains over time. In patients in the control group, it is anticipated that there will be no difference in follow-up measures between the different times or the presence of decreased performance as these patients are at risk of developing neurodegenerative pathology. In a preliminary study evaluating the efficacy of the APT-II programme by the same team of research, six MCI patients (m = 68 ± 10.56 years) attended 10 sessions of the APT-II programme (2 sessions/week). Statistical analyses indicate that after cognitive training, MCI patients tended to improve their performance on a working memory task (upside down number span, p = .06). There was also a gain in daily activities and well-being, as assessed by the Cognitive Failure Questionnaire (p = .04) and the Bravo Wellness Questionnaire (p = .04), respectively. These encouraging results support the effectiveness of the APT-II program in IBD patients. They remain to be confirmed on larger samples with a randomized controlled trial. This project could provide the clinic with a standardized cognitive intervention tool for better cognitive management of these patients. The clinical impact of the project will hopefully be significant.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75020
- SABA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- MCI criteria according to Petersen 2004
- 55 years and over
- Native French-speaking or bilingual participant living in the Paris region
- Normal or corrected vision and hearing
- Presence of episodic memory and/or attention and/or working memory impairment as evidenced by substandard performance on neuropsychological test(s) evaluating these processes (-1.5 deviations from the norms)
Exclusion Criteria:
- Presence of dementia
- Significant impact of cognitive impairment on activities of daily living requiring external assistance or institutionalization
- Stroke or brain injury
- Presence of moderate to severe psychiatric disorders
- Ethylism
- General anesthesia in the last six months
- Treatment directly impacting cognition
- Patient with significant depression (cut off GDS > 10)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Attention Process Training (APT-II)
Patients in the experimental group receive the APT-II training program (Attention Process Training) individually with a psychologist for 8 weeks (2 sessions/week).
The exercises target different attentional components and working memory in the auditory-visual modalities.
They are of increasing difficulty while being adapted to each patient's profile in order to maximize the effects on cognitive reserve.
During the sessions, the emphasis is on generalizing the gains towards the most problematic daily activities in order to reduce the impact of the patients' cognitive problems in their daily lives.
|
The exercises target different attentional components and working memory in the auditory-visual modalities.
They are of increasing difficulty while being adapted to the profile of each patient in order to maximize the effects on cognitive reserve.
During the sessions, the emphasis is on generalizing the gains to the most problematic daily activities in order to reduce the impact of cognitive disorders in patients' daily life.
|
|
No Intervention: Standard care
Patients in the control group receive standard routine care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini Mental State MMSE
Time Frame: Prior the program
|
The mini-mental state (MMS) or mini-mental state examination (MMSE) or Folstein test is a test for the evaluation of global cognitive functions.
This test is used for diagnostic purposes when there is a suspicion of dementia and cognitive disorders.
It evaluates temporospatial orientation, memory, attention, language and praxies.
Folstein, Folstein and McHugh, 1975; Greco version.
|
Prior the program
|
|
Mini Mental State MMSE
Time Frame: Immediately after the program
|
The mini-mental state (MMS) or mini-mental state examination (MMSE) or Folstein test is a test for the evaluation of global cognitive functions.
This test is used for diagnostic purposes when there is a suspicion of dementia and cognitive disorders.
It evaluates temporospatial orientation, memory, attention, language and praxies.
Folstein, Folstein and McHugh, 1975; Greco version.
|
Immediately after the program
|
|
Mini Mental State MMSE
Time Frame: 3 months follow-up
|
The mini-mental state (MMS) or mini-mental state examination (MMSE) or Folstein test is a test for the evaluation of global cognitive functions.
This test is used for diagnostic purposes when there is a suspicion of dementia and cognitive disorders.
It evaluates temporospatial orientation, memory, attention, language and praxies.
Folstein, Folstein and McHugh, 1975; Greco version.
|
3 months follow-up
|
|
Mini Mental State MMSE
Time Frame: 6 months follow-up
|
The mini-mental state (MMS) or mini-mental state examination (MMSE) or Folstein test is a test for the evaluation of global cognitive functions.
This test is used for diagnostic purposes when there is a suspicion of dementia and cognitive disorders.
It evaluates temporospatial orientation, memory, attention, language and praxies.
Folstein, Folstein and McHugh, 1975; Greco version.
|
6 months follow-up
|
|
Digit span
Time Frame: Prior the program
|
The Digit span task is a test evaluating the phonological loop and executive control capabilities of the working memory.
The test consists of hearing a series of numbers orally by the examiner and must repeat the same series in the same order or in reverse.
This test measures the limited capabilities of a specialized verbal short-term memory system described by Baddeley and Hitch (1974).
WAIS-III Weschler,2000 and MEM-III Weschler 2001
|
Prior the program
|
|
Digit span
Time Frame: Immediately after the program
|
The Digit span task is a test evaluating the phonological loop and executive control capabilities of the working memory.
The test consists of hearing a series of numbers orally by the examiner and must repeat the same series in the same order or in reverse.
This test measures the limited capabilities of a specialized verbal short-term memory system described by Baddeley and Hitch (1974).
WAIS-III Weschler,2000 and MEM-III Weschler 2001
|
Immediately after the program
|
|
Digit span
Time Frame: 3 months follow-up
|
The Digit span task is a test evaluating the phonological loop and executive control capabilities of the working memory.
The test consists of hearing a series of numbers orally by the examiner and must repeat the same series in the same order or in reverse.
This test measures the limited capabilities of a specialized verbal short-term memory system described by Baddeley and Hitch (1974).
WAIS-III Weschler,2000 and MEM-III Weschler 2001
|
3 months follow-up
|
|
Digit span
Time Frame: 6 months follow-up
|
The Digit span task is a test evaluating the phonological loop and executive control capabilities of the working memory.
The test consists of hearing a series of numbers orally by the examiner and must repeat the same series in the same order or in reverse.
This test measures the limited capabilities of a specialized verbal short-term memory system described by Baddeley and Hitch (1974).
WAIS-III Weschler,2000 and MEM-III Weschler 2001
|
6 months follow-up
|
|
PASAT (Naegele and Mazza, 2004)
Time Frame: Prior the program
|
PASAT is a test that evaluates information processing skills, sustained attention, and shared attention.
The individual hears numbers in succession with an interval of 4 seconds.
He must add the last digit heard to the last given without losing his attention.
|
Prior the program
|
|
PASAT (Naegele and Mazza, 2004)
Time Frame: Immediately after the program
|
PASAT is a test that evaluates information processing skills, sustained attention, and shared attention.
The individual hears numbers in succession with an interval of 4 seconds.
He must add the last digit heard to the last given without losing his attention.
|
Immediately after the program
|
|
PASAT (Naegele and Mazza, 2004)
Time Frame: 3 months follow-up
|
PASAT is a test that evaluates information processing skills, sustained attention, and shared attention.
The individual hears numbers in succession with an interval of 4 seconds.
He must add the last digit heard to the last given without losing his attention.
|
3 months follow-up
|
|
PASAT (Naegele and Mazza, 2004)
Time Frame: 6 months follow-up
|
PASAT is a test that evaluates information processing skills, sustained attention, and shared attention.
The individual hears numbers in succession with an interval of 4 seconds.
He must add the last digit heard to the last given without losing his attention.
|
6 months follow-up
|
|
Brown Peterson's Paradigm (Peterson and Peterson, 1959)
Time Frame: Prior the program
|
Experimental technique to study forgetting in short-term memory and also used as a measure of the central administrator of working memory.
The task is to present the subjects with sequences of three consonants.
After the presentation of each sequence, the subject is asked to either perform an immediate recall of the consonants or to perform a countdown task from 30 seconds, 20 seconds or 10 seconds.
At the end of this count, the subject must give the series again starting from 3 consonants.
|
Prior the program
|
|
Brown Peterson's Paradigm (Peterson and Peterson, 1959)
Time Frame: Immediately after the program
|
Experimental technique to study forgetting in short-term memory and also used as a measure of the central administrator of working memory.
The task is to present the subjects with sequences of three consonants.
After the presentation of each sequence, the subject is asked to either perform an immediate recall of the consonants or to perform a countdown task from 30 seconds, 20 seconds or 10 seconds.
At the end of this count, the subject must give the series again starting from 3 consonants.
|
Immediately after the program
|
|
Brown Peterson's Paradigm (Peterson and Peterson, 1959)
Time Frame: 3 months follow-up
|
Experimental technique to study forgetting in short-term memory and also used as a measure of the central administrator of working memory.
The task is to present the subjects with sequences of three consonants.
After the presentation of each sequence, the subject is asked to either perform an immediate recall of the consonants or to perform a countdown task from 30 seconds, 20 seconds or 10 seconds.
At the end of this count, the subject must give the series again starting from 3 consonants.
|
3 months follow-up
|
|
Brown Peterson's Paradigm (Peterson and Peterson, 1959)
Time Frame: 6 months follow-up
|
Experimental technique to study forgetting in short-term memory and also used as a measure of the central administrator of working memory.
The task is to present the subjects with sequences of three consonants.
After the presentation of each sequence, the subject is asked to either perform an immediate recall of the consonants or to perform a countdown task from 30 seconds, 20 seconds or 10 seconds.
At the end of this count, the subject must give the series again starting from 3 consonants.
|
6 months follow-up
|
|
Virtual reality memory task
Time Frame: Prior the program
|
A developed virtual reality task was also administered to the participants to allow a more ecological analysis of episodic memory and divided attention.
|
Prior the program
|
|
Virtual reality memory task
Time Frame: Immediately after the program
|
A developed virtual reality task was also administered to the participants to allow a more ecological analysis of episodic memory and divided attention.
|
Immediately after the program
|
|
Continious Performance task CPT
Time Frame: Prior the program
|
CPT is a task of sustained and selective attention on the computer.
The task consists of clicking on the space bar of the computer when a letter is presented on the screen except for the letter "X".
The person should not click if they see the letter "X" presented.
This test takes several minutes.
|
Prior the program
|
|
Continious Performance task CPT
Time Frame: Immediately after the program
|
CPT is a task of sustained and selective attention on the computer.
The task consists of clicking on the space bar of the computer when a letter is presented on the screen except for the letter "X".
The person should not click if they see the letter "X" presented.
This test takes several minutes.
|
Immediately after the program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Failure Questionnaire
Time Frame: Prior the program
|
The Cognitive Failure Questionnaire (CFQ) is a questionnaire that evaluates daily cognitive failures.
|
Prior the program
|
|
Cognitive Failure Questionnaire
Time Frame: Immediately after the program
|
The Cognitive Failure Questionnaire (CFQ) is a questionnaire that evaluates daily cognitive failures.
|
Immediately after the program
|
|
Cognitive Failure Questionnaire
Time Frame: 3 months follow-up
|
The Cognitive Failure Questionnaire (CFQ) is a questionnaire that evaluates daily cognitive failures.
|
3 months follow-up
|
|
Cognitive Failure Questionnaire
Time Frame: 6 months follow-up
|
The Cognitive Failure Questionnaire (CFQ) is a questionnaire that evaluates daily cognitive failures.
|
6 months follow-up
|
|
Bravo's Scale
Time Frame: Prior the program
|
This scale is a measure of general well-being. The questionnaire contains 18 items that determine how the respondent feels. The first fourteen questions are answered on a 6-point Likert scale (0-5) and the last four questions on a 10-point scale (0-10) to give a maximum score of 110. A high well-being score is close to 110. |
Prior the program
|
|
Bravo's Scale
Time Frame: Immediately after the program
|
This scale is a measure of general well-being. The questionnaire contains 18 items that determine how the respondent feels. The first fourteen questions are answered on a 6-point Likert scale (0-5) and the last four questions on a 10-point scale (0-10) to give a maximum score of 110. A high well-being score is close to 110. |
Immediately after the program
|
|
Bravo's Scale
Time Frame: 3 months follow-up
|
This scale is a measure of general well-being. The questionnaire contains 18 items that determine how the respondent feels. The first fourteen questions are answered on a 6-point Likert scale (0-5) and the last four questions on a 10-point scale (0-10) to give a maximum score of 110. A high well-being score is close to 110. |
3 months follow-up
|
|
Bravo's Scale
Time Frame: 6 months follow-up
|
This scale is a measure of general well-being. The questionnaire contains 18 items that determine how the respondent feels. The first fourteen questions are answered on a 6-point Likert scale (0-5) and the last four questions on a 10-point scale (0-10) to give a maximum score of 110. A high well-being score is close to 110. |
6 months follow-up
|
|
APT-II Attention Questionnaire
Time Frame: Prior the program
|
The attention questionnaire is a questionnaire of the attention complaint felt by the subject in everyday life.
This questionnaire is taken from the APT program.
|
Prior the program
|
|
APT-II Attention Questionnaire
Time Frame: Immediately after the program
|
The attention questionnaire is a questionnaire of the attention complaint felt by the subject in everyday life.
This questionnaire is taken from the APT program.
|
Immediately after the program
|
|
APT-II Attention Questionnaire
Time Frame: 3 months follow-up
|
The attention questionnaire is a questionnaire of the attention complaint felt by the subject in everyday life.
This questionnaire is taken from the APT program.
|
3 months follow-up
|
|
APT-II Attention Questionnaire
Time Frame: 6 months follow-up
|
The attention questionnaire is a questionnaire of the attention complaint felt by the subject in everyday life.
This questionnaire is taken from the APT program.
|
6 months follow-up
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Sophie SB Blanchet, Ph.D, University of Paris
Publications and helpful links
General Publications
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 Mar;56(3):303-8. doi: 10.1001/archneur.56.3.303. Erratum In: Arch Neurol 1999 Jun;56(6):760.
- Baddeley A, Logie R, Bressi S, Della Sala S, Spinnler H. Dementia and working memory. Q J Exp Psychol A. 1986 Nov;38(4):603-18. doi: 10.1080/14640748608401616. No abstract available.
- Barker-Collo SL, Feigin VL, Lawes CM, Parag V, Senior H, Rodgers A. Reducing attention deficits after stroke using attention process training: a randomized controlled trial. Stroke. 2009 Oct;40(10):3293-8. doi: 10.1161/STROKEAHA.109.558239. Epub 2009 Jul 23.
- Belleville S, Boller B. Comprendre le stade compensatoire de la maladie d'Alzheimer et agir pour promouvoir la cognition et la plasticite cerebrale. Can J Exp Psychol. 2016 Dec;70(4):288-294. doi: 10.1037/cep0000087.
- Blanchet S, McCormick L, Belleville S, Gely-Nargeot MC, Joanette Y. [Mild cognitive impairments in the elderly: a critical review]. Rev Neurol (Paris). 2002 Jan;158(1):29-39. French.
- Kim H, Chey J, Lee S. Effects of multicomponent training of cognitive control on cognitive function and brain activation in older adults. Neurosci Res. 2017 Nov;124:8-15. doi: 10.1016/j.neures.2017.05.004. Epub 2017 Jun 1.
- Palmese CA, Raskin SA. The rehabilitation of attention in individuals with mild traumatic brain injury, using the APT-II programme. Brain Inj. 2000 Jun;14(6):535-48. doi: 10.1080/026990500120448.
- Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A. Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.
- Plancher G, Gyselinck V, Piolino P. The Integration of Realistic Episodic Memories Relies on Different Working Memory Processes: Evidence from Virtual Navigation. Front Psychol. 2018 Jan 30;9:47. doi: 10.3389/fpsyg.2018.00047. eCollection 2018.
- Saba M, Blanchet S. [Working memory training in normal and pathological aging: neurocognitive gains and generalization]. Geriatr Psychol Neuropsychiatr Vieil. 2020 Jun 1;18(2):187-195. doi: 10.1684/pnv.2020.0860. French.
- Simon SS, Tusch ES, Feng NC, Hakansson K, Mohammed AH, Daffner KR. Is Computerized Working Memory Training Effective in Healthy Older Adults? Evidence from a Multi-Site, Randomized Controlled Trial. J Alzheimers Dis. 2018;65(3):931-949. doi: 10.3233/JAD-180455.
- Telonio A, Blanchet S, Maganaris CN, Baltzopoulos V, Villeneuve S, McFadyen BJ. The division of visual attention affects the transition point from level walking to stair descent in healthy, active older adults. Exp Gerontol. 2014 Feb;50:26-33. doi: 10.1016/j.exger.2013.11.007. Epub 2013 Nov 27. Erratum In: Exp Gerontol. 2015 Jan;61:156.
- Murray LL, Keeton RJ, Karcher L. Treating attention in mild aphasia: evaluation of attention process training-II. J Commun Disord. 2006 Jan-Feb;39(1):37-61. doi: 10.1016/j.jcomdis.2005.06.001. Epub 2005 Jul 21.
- Unsworth N, Fukuda K, Awh E, Vogel EK. Working memory and fluid intelligence: capacity, attention control, and secondary memory retrieval. Cogn Psychol. 2014 Jun;71:1-26. doi: 10.1016/j.cogpsych.2014.01.003. Epub 2014 Feb 14.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APT-II Project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
-
Xuanwu Hospital, BeijingEnrolling by invitation
-
Beijing Tiantan HospitalNot yet recruiting
-
Danyang Huichuang Medical Equipment Co., Ltd.RecruitingAlzheimer s DiseaseChina
Clinical Trials on Attention Process Training (APT-II)
-
Azienda Ospedaliero-Universitaria CareggiMinistero della Salute, ItalyCompletedMild Cognitive ImpairmentItaly
-
Shirley Ryan AbilityLabCompleted
-
Pietro IaffaldanoCompletedADHD Predominantly Inattentive Type | Pediatric Onset Multiple Sclerosis
-
Northwestern UniversityRecruitingPost Traumatic Stress Disorder | Mild Traumatic Brain InjuryUnited States
-
University of New MexicoMinneapolis Veterans Affairs Medical Center; University of Minnesota; The Mind... and other collaboratorsRecruitingTraumatic Brain InjuryUnited States
-
VA Office of Research and DevelopmentCompletedMild Traumatic Brain InjuryUnited States
-
Karolinska InstitutetRegion Stockholm; Promobilia Foundation; Stroke Foundation; KID-medelCompleted
-
Technical University of MunichGerman Research Foundation; Studienstiftung des deutschen VolkesCompletedExperimental Pain in Healthy Human SubjectsGermany
-
Mclean HospitalTerminatedDepression | Attention Training | Symptoms, Cognitive | Symptoms, Affective | Symptoms, BehavioralUnited States
-
Joseph Brant HospitalUnknownDepressive Symptoms | Anxiety SymptomsCanada